A confirmed first-line option for CLL

被引:0
|
作者
Rebecca Kirk
机构
关键词
D O I
10.1038/nrclinonc.2011.38
中图分类号
学科分类号
摘要
引用
收藏
页码:253 / 253
相关论文
共 50 条
  • [1] New first-line options in CLL
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (09) : 526 - 527
  • [2] New first-line options in CLL
    Diana Romero
    Nature Reviews Clinical Oncology, 2019, 16 : 526 - 527
  • [3] Surgery as a first-line option for prolactinomas
    Mamelak, Adam
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (06) : 485 - 498
  • [4] First-line therapy for young patients with CLL
    Jain, Nitin
    O'Brien, Susan
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 146 - 148
  • [5] Factors influencing First-Line Treatment in CLL
    Dilhuydy, Marie-Sarah
    HEMATOLOGIE, 2024, 30 : 13 - 18
  • [6] Ibrutinib and Venetoclax for First-Line Treatment of CLL
    Jain, Nitin
    Keating, Michael
    Thompson, Philip
    Ferrajoli, Alessandra
    Burger, Jan
    Borthakur, Gautam
    Takahashi, Koichi
    Estrov, Zeev
    Fowler, Nathan
    Kadia, Tapan
    Konopleva, Marina
    Alvarado, Yesid
    Yilmaz, Musa
    DiNardo, Courtney
    Bose, Prithviraj
    Ohanian, Maro
    Pemmaraju, Naveen
    Jabbour, Elias
    Sasaki, Koji
    Kanagal-Shamanna, Rashmi
    Patel, Keyur
    Jorgensen, Jeffrey
    Garg, Naveen
    Wang, Xuemei
    Sondermann, Katrina
    Cruz, Nichole
    Wei, Chongjuan
    Ayala, Ana
    Plunkett, William
    Kantarjian, Hagop
    Gandhi, Varsha
    Wierda, William
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (22): : 2095 - 2103
  • [7] Ibrutinib and Venetoclax for First-Line Treatment of CLL
    Kater, Arnon P.
    Levin, Mark-David
    Niemann, Carsten U.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (08): : 788 - 789
  • [10] Lenalidomide as first-line therapy for elderly CLL patients
    Gilbert, Judith A.
    LANCET ONCOLOGY, 2013, 14 (09): : E345 - E345